News Category
NanoViricides has received approval to start a Phase II trial of its oral antiviral NV-387 for Ebola in the DRC, potentially offering a more accessibl...
Research from the University of Virginia suggests focused ultrasound can enhance drug delivery to gliomas, potentially improving brain cancer treatmen...
Telomir Pharmaceuticals announced peer-reviewed preclinical data showing Telomir-Zn suppresses tumor growth in triple-negative breast cancer models, s...
A new narrative review provides a comprehensive framework for risk-adapted neuroblastoma care, emphasizing molecular and clinical factors to tailor tr...
Quantum BioPharma advances a two-pronged approach to neurological health, combining its investigational MS therapy Lucid-MS with its supplement unbuzz...
A Spanish patient initially treated for brain cancer was found to have pork tapeworm cysts, underscoring the importance of proper pork preparation and...
VERAXA Biotech has advanced its VXA-222 bispecific ADC program past the discovery phase and expanded its patent portfolio, underscoring its progress i...
The Keep A Breast Foundation's 2026 High Desert Collection uses art to spark breast health conversations, launching in Pioneertown and expanding along...
A novel liquid biopsy offers a simpler method to predict which advanced lung cancer patients will respond to immunotherapy, potentially improving trea...
GeoVax announces completion of manufacturing, regulatory, clinical, and preclinical milestones for its GEO-MVA mpox/smallpox vaccine, positioning it f...
Onco-Innovations is combining PNKP-targeted DDR inhibition, nanoparticle delivery, and causal AI to accelerate cancer drug development, with lead cand...
Nagoya University researchers discovered that the immune protein C3, when produced within tumors, can make them more susceptible to immunotherapy, pot...
VolitionRx's new Capture-Seq technology achieves >99% pure ctDNA isolation, potentially transforming cancer detection and monitoring, with a combined ...
VERAXA Biotech has advanced its VXA-222 bispecific antibody-drug conjugate into the next development stage and expanded its patent portfolio, strength...
The American Heart Association honors over 3,000 hospitals for improving cardiovascular care through Get With The Guidelines, highlighting the growing...
The US surpasses its 2025 measles case total, reaching a 30-year high, highlighting the urgent need for robust contact tracing and vaccination efforts...
Oncotelic Therapeutics is set to present at the OTCQB Virtual Investor Conference, showcasing progress in its Phase 1b trial, platform validation, and...
Recent independent findings suggest cross-reactive immune responses among ebolaviruses, reinforcing the strategic importance of GeoVax's multi-antigen...
Amber Dermatology, founded by Dr. Alyssa Miceli, opens in Trumbull, CT, aiming to transform dermatology with a patient-centered, relationship-driven a...
Experts warn that climate change is accelerating the spread of infectious diseases, posing a growing public health threat that policymakers are not ad...
VERAXA Biotech strengthens scientific leadership with a new CSO as it advances its proprietary BiTAC® platform toward clinical development, positionin...
Onco-Innovations Limited closed a CAD$5 million private placement with Sorbie Bornholm LP and Sorbie Investments LLP, providing funding to advance its...
Dr. Lee Newcomer, a former UnitedHealthcare chief medical officer and health policy expert, has partnered with Creative Management Partners and agent ...
A preclinical study reveals an experimental therapy containing vitamin B12 could halt glioblastoma multiforme, the deadliest brain cancer, offering ne...
VolitionRx Limited announces that multiple peer-reviewed studies confirm its Nu.Q H3.1 test can distinguish sepsis from non-infectious inflammation, c...
VERAXA Biotech has expanded its patent portfolio with new filings covering its BiTAC-TCE and BiTAC-ADC platforms, strengthening protection through 204...
VERAXA Biotech strengthens its scientific leadership with the appointment of Dr. Christoph Erkel as Chief Scientific Officer, positioning the company ...
VERAXA Biotech AG announced the expansion of its intellectual property portfolio with new patent applications covering its BiTAC-TCE and BiTAC-ADC pla...
Dr. Edward H. Davidson, a board-certified plastic surgeon at Palm Beach Plastic Surgery Institute, has been named a 2026 Castle Connolly Top Doctor, a...
A new study aims to explore why some individuals with cancer risk factors avoid the disease, while others without risk factors develop cancer, focusin...
The EMA clearance for Lantern Pharma’s biomarker-guided Phase 1b/2 trial of LP-184 in advanced bladder cancer marks a key step in advancing AI-driven ...
The global flow cytometry diagnostics market is projected to grow from USD 1.5 billion in 2026 to USD 3.5 billion by 2036 at an 8.9% CAGR, driven by r...
GeoVax Labs reports Q2 2026 financial results, advancing its GEO-MVA vaccine candidate toward a pivotal immunobridging study under an expedited regula...
Onco-Innovations is progressing its lead PNKP inhibitor ONC010, with advancements in kilogram-scale manufacturing, drug delivery partnerships, and cli...
Research in Nature Medicine indicates experimental immunotherapy may offer relief for pediatric patients with aggressive brain and spinal cord tumors,...
VERAXA Biotech announced the advancement of its bispecific antibody-drug conjugate program VXA-222 after OmniAb completed discovery work, moving the p...
Onco-Innovations combines a novel PNKP inhibitor with nanoparticle delivery and AI-driven trial design to address resistance, trial failures, and drug...
VERAXA Biotech appointed Christoph Erkel as CSO to advance its BiTAC platform for solid tumor therapies, leveraging his expertise in antibody engineer...
VERAXA Biotech has obtained Scientific Advice from Germany's Paul-Ehrlich-Institute supporting its development strategy for the lead BiTAC®-TCE progra...
Onco-Innovations is developing ONC010, a nanoparticle-encapsulated PNKP inhibitor for biomarker-selected cancers, aligning with the industry shift tow...
Recent outbreaks of measles, mpox, and HIV in the U.S. have revealed critical weaknesses in public health systems, as highlighted by Dr. Monica Gandhi...
Lantern Pharma's receipt of a U.S. patent allowance for methods using a three-gene biomarker signature to select patients for LP-184 treatment advance...
VERAXA Biotech AG announced the appointment of Christoph Erkel as Chief Scientific Officer, effective immediately, to lead the development of its prop...
iOrganBio expands its Scientific Advisory Board with stem cell biology authority Lee L. Rubin, Ph.D., aiming to enhance its CellForge platform for neu...
Quantum BioPharma is advancing a pipeline addressing multiple sclerosis with its novel drug Lucid-MS and alcohol-related cognitive effects with unbuzz...
Oncotelic Therapeutics released preclinical data in Biomedicines for its intravenous everolimus formulation Sapu003, showing improved pharmacokinetics...
A new study indicates that the ratio of polyunsaturated to monounsaturated fats in the diet may affect immune cell membrane composition and vulnerabil...
Kairos Pharma Ltd. has partnered with Bayer to study its lead antibody ENV-105 in combination with XOFIGO for metastatic castration-resistant prostate...
